Uncategorized

NanOlogy Granted a US Patent for Its Investigational Drugs in Combination with Immune Checkpoint Inhibitors in the Treatment of Cancer

NanOlogy LLC, a clinical-stage oncology company, announced issuance of a US patent titled: Local Delivery of Antineoplastic Particles in Combination with Systemic Delivery of Immunotherapeutic Agents for the Treatment of Cancer.

NanOlogy Granted a US Patent for Its Investigational Drugs in Combination with Immune Checkpoint Inhibitors in the Treatment of Cancer Read More »

New Study Shows High Patient Satisfaction and Outcomes After Outpatient Joint Arthroplasty at Academic Medical Centers

In the first study to establish patient satisfaction after outpatient total joint arthroplasty in an academic medical center setting, patients indicated they were very likely to undergo the outpatient procedure again and had high patient reported outcomes.

New Study Shows High Patient Satisfaction and Outcomes After Outpatient Joint Arthroplasty at Academic Medical Centers Read More »

Older Patients Shown to Exhibit Better Pain Relief, Quality of Life Than Younger Patients Following Total Knee Arthroplasty

Patients aged 55 and younger were found to have worse pain, function and quality of life following total knee arthroplasty compared to patients 75 years and older, according to a study presented at the 2023 Annual Meeting of the American Academy of Orthopaedic Surgeons that looked at age-related differences in patient outcomes following TKA.

Older Patients Shown to Exhibit Better Pain Relief, Quality of Life Than Younger Patients Following Total Knee Arthroplasty Read More »

Scroll to Top